Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02562443
Title Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA (INSPIRE)
Acronym INSPIRE
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Onconova Therapeutics, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | SWE | POL | ITA | ISR | IRL | HUN | HRV | GBR | FRA | EST | ESP | DEU | CZE | CHE | CAN | BEL | AUT | AUS


No variant requirements are available.